Research Capital Corporation – Additional Phase 2a Analysis by a Chronic Cough KOL
We are maintaining our SPECULATIVE BUY rating & C$25 Target …
Pulmonary Fibrosis News – NP-120, Potential IPF Treatment, Stabilizes Lung Function in Trial
Most idiopathic pulmonary fibrosis (IPF) patients treated …
Streetwise Reports – Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity
Patients in Algernon’s Phase 2a Study Show Improved Lung Capacity …